ValuEngine cut shares of Molina Healthcare (NYSE:MOH) from a sell rating to a strong sell rating in a research note published on Thursday, ValuEngine reports.

Several other analysts have also recently commented on MOH. Bank of America restated an underperform rating and issued a $140.00 price target (up previously from $132.00) on shares of Molina Healthcare in a report on Wednesday, July 31st. Wells Fargo & Co upgraded Molina Healthcare from a market perform rating to an outperform rating and set a $177.00 price target for the company in a report on Friday, May 31st. Deutsche Bank initiated coverage on Molina Healthcare in a report on Thursday. They issued a buy rating and a $145.00 price target for the company. Barclays lifted their price target on Molina Healthcare from $140.00 to $149.00 and gave the company an equal weight rating in a report on Friday, May 31st. Finally, BMO Capital Markets upgraded Molina Healthcare from a market perform rating to an outperform rating and lifted their price target for the company from $154.00 to $200.00 in a report on Monday, June 3rd. Two research analysts have rated the stock with a sell rating, five have issued a hold rating, eight have given a buy rating and one has assigned a strong buy rating to the stock. The stock presently has an average rating of Buy and an average target price of $160.83.

Molina Healthcare stock traded up $0.99 during midday trading on Thursday, reaching $114.93. 38,993 shares of the company were exchanged, compared to its average volume of 497,109. The company has a market capitalization of $7.51 billion, a price-to-earnings ratio of 10.38, a P/E/G ratio of 1.09 and a beta of 1.20. The firm’s 50-day simple moving average is $130.70 and its 200-day simple moving average is $136.33. Molina Healthcare has a 1 year low of $105.28 and a 1 year high of $159.00. The company has a debt-to-equity ratio of 0.85, a quick ratio of 1.73 and a current ratio of 1.73.

Molina Healthcare (NYSE:MOH) last posted its quarterly earnings data on Tuesday, July 30th. The company reported $3.11 EPS for the quarter, topping analysts’ consensus estimates of $2.56 by $0.55. The firm had revenue of $4.19 billion during the quarter, compared to analysts’ expectations of $4.08 billion. Molina Healthcare had a return on equity of 51.49% and a net margin of 4.48%. The firm’s quarterly revenue was down 14.1% compared to the same quarter last year. During the same quarter last year, the business posted $3.08 EPS. On average, analysts forecast that Molina Healthcare will post 11.4 EPS for the current fiscal year.

In other news, Director Ronna Romney sold 375 shares of the business’s stock in a transaction dated Thursday, August 8th. The stock was sold at an average price of $131.63, for a total transaction of $49,361.25. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. 0.77% of the stock is currently owned by insiders.

Several large investors have recently modified their holdings of MOH. Boston Partners acquired a new position in Molina Healthcare during the 2nd quarter worth approximately $82,898,000. BlackRock Inc. lifted its holdings in shares of Molina Healthcare by 0.4% in the second quarter. BlackRock Inc. now owns 5,752,811 shares of the company’s stock valued at $823,458,000 after buying an additional 22,368 shares during the period. Barings LLC lifted its holdings in shares of Molina Healthcare by 17.6% in the second quarter. Barings LLC now owns 2,740 shares of the company’s stock valued at $392,000 after buying an additional 410 shares during the period. Royal Bank of Canada lifted its holdings in shares of Molina Healthcare by 85.0% in the second quarter. Royal Bank of Canada now owns 126,953 shares of the company’s stock valued at $18,172,000 after buying an additional 58,341 shares during the period. Finally, Amundi Pioneer Asset Management Inc. lifted its holdings in shares of Molina Healthcare by 65.6% in the second quarter. Amundi Pioneer Asset Management Inc. now owns 82,601 shares of the company’s stock valued at $11,824,000 after buying an additional 32,727 shares during the period. Institutional investors and hedge funds own 96.99% of the company’s stock.

Molina Healthcare Company Profile

Molina Healthcare, Inc provides Medicaid-related solutions to meet the health care needs of low-income families and individuals; and to assist state agencies in their administration of the Medicaid program in the United States. It operates through three segments: Health Plans, Molina Medicaid Solutions, and Other.

Featured Story: Leveraged Buyout (LBO) Explained

To view ValuEngine’s full report, visit ValuEngine’s official website.

Analyst Recommendations for Molina Healthcare (NYSE:MOH)

Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.